Edison Biotechnology Institute
Yunsheng Li has not added Biography.
If you are Yunsheng Li and would like to personalize this page please email our Author Liaison for assistance.
Seryl-histidine as an alternative DNA nicking agent in nick translation yields superior DNA probes and hybridizations.
Bioorganic & medicinal chemistry Mar, 2002 | Pubmed ID: 11814854
Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells.
The Journal of nutrition Feb, 2005 | Pubmed ID: 15671208
Natural anti-diabetic compound 1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin receptor and activates insulin-mediated glucose transport signaling pathway.
Biochemical and biophysical research communications Oct, 2005 | Pubmed ID: 16137651
Orally efficacious novel small molecule 6-chloro-6-deoxy-1,2,3,4-tetra-O-galloyl-α-D-glucopyranose selectively and potently stimulates insulin receptor and alleviates diabetes.
Journal of molecular endocrinology , 2013 | Pubmed ID: 23549408
Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells.
Cancer letters Sep, 2014 | Pubmed ID: 24973521
Extracellular ATP a New Player in Cancer Metabolism: NSCLC Cells Internalize ATP In Vitro and In Vivo Using Multiple Endocytic Mechanisms.
Molecular cancer research : MCR 11, 2016 | Pubmed ID: 27578770
Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase.
Oncotarget Oct, 2017 | Pubmed ID: 29152126
Extracellular and macropinocytosis internalized ATP work together to induce epithelial-mesenchymal transition and other early metastatic activities in lung cancer.
Cancer cell international , 2019 | Pubmed ID: 31582910
Natural Compound α-PGG and Its Synthetic Derivative 6Cl-TGQ Alter Insulin Secretion: Evidence for Diminishing Glucose Uptake as a Mechanism.
Diabetes, metabolic syndrome and obesity : targets and therapy , 2021 | Pubmed ID: 33658814
A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism.
Cancer & metabolism Mar, 2021 | Pubmed ID: 33771231
Corinne M. Nielsen*,1,2,3,
Yanrong Qian*,4,
Subhodip Adhicary1,5,
Yunsheng Li4,
Pratik Shriwas1,2,4,
Xuan Wang1,2,4,
Lindsey Bachmann6,
Xiaozhuo Chen1,2,4,7
1Department of Biological Sciences, Ohio University,
2Molecular and Cellular Biology Program, Ohio University,
3Neuroscience Program, Ohio University,
4Edison Biotechnology Institute, Ohio University,
5Translational Biomedical Sciences Program, Ohio University,
6Honors Tutorial College, Ohio University,
7Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유